Leukemia Decision Support for Clinical Teams

Haem.io (Haemio) is a hematology decision-support platform built to help teams review high-complexity leukemia and myeloid disease classification criteria. It combines deterministic algorithmic execution with explainable, clinician-verifiable logic.

The current product scope supports AML and MDS pathways. Broader leukemia coverage is part of the roadmap, and this page will expand as additional disease modules become production-ready.

Current capabilities

• WHO 2022 and ICC 2022 classification logic for AML and MDS
• Risk stratification support for AML and MDS contexts
• Traceable criteria paths for every classification support output
• Human-in-the-loop workflow: clinicians verify inputs and retain final judgement